GEN Exclusives

More »

GEN News Highlights

Back to Item »

Crescendo Bioscience Pockets $56M and Gives Buyout Option to Myriad

Myriad made a $25 million debt investment, gaining the ability to acquire Crescendo.

Forward this item to a colleague:


(Separate multiple addresses by commas)


(Separate multiple addresses by commas)


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

GEN Poll

More » Poll Results »

Moral Calculations May Shift Biobank Balances

How should consent terms reconcile donors’ moral concerns with biobanks’ research goals?